Of note, inhibition of FOXM1 suppressed growth of primary MA9 leukemia cells in vivo in mice, as evidenced by a lower percentage of human donor cells present in PB cells (Fig. 9a–c) in FOXM1-specific peptide-treated xenografted mice as compared to PBS-treated mice. The gene discussed is FOXM1; the disease is leukemia.